PRESS DIGEST-Financial Times - July 29

- Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course, higher than other vaccine makers have agreed to charge governments, according to people familiar with talks between the company and potential buyers. - British online health and beauty retailer Hut Group which is valued at more than 4 billion pounds ($5.17 billion) has appointed a slate of investment banks ahead of a possible IPO this year, according to two people familiar with the process.

The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines

- Rio Tinto in talks with SFO over bribery probe deal https://on.ft.com/312suPo - TransferWise valued at $5bn in secondary share sale https://on.ft.com/3jQXFWr

- Moderna pitches virus vaccine at about $50-$60 per course https://on.ft.com/2BExd0X - Hut Group appoints banks for possible IPO https://on.ft.com/3f84Shb

Overview - Rio Tinto Plc is in talks with the UK's Serious Fraud Office seeking a deferred prosecution agreement over a payment it made to a consultant working on a contentious iron ore deposit in Guinea.

- Cross-border payments group TransferWise said the company has sold $319 million worth of shares in a secondary share sale that values the London-based money transfer company at $5 billion. - Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course, higher than other vaccine makers have agreed to charge governments, according to people familiar with talks between the company and potential buyers.

- British online health and beauty retailer Hut Group which is valued at more than 4 billion pounds ($5.17 billion) has appointed a slate of investment banks ahead of a possible IPO this year, according to two people familiar with the process. ($1 = 0.7737 pounds)

(Compiled by Bengaluru newsroom)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)